Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bicarbonate for prevention of contrast-induced nephropathy in elective coronary angiography
ACTRN12608000205336Phase 4Recruiting
- Sponsor
- Michael Mok
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sodium bicarbonate in contrast-induced nephropathy (CIN), sponsored by Michael Mok. Started Apr 2008; status: recruiting.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on ACTRN12608000205336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000205336.